226 related articles for article (PubMed ID: 36032133)
81. Chronic active Epstein-Barr virus infection presenting as refractory chronic sinusitis.
Kitamura W; Fujiwara H; Matsumura A; Higaki T; Shibata R; Toji T; Fujii S; Asada N; Ennishi D; Nishimori H; Fujii K; Fujii N; Matsuoka KI; Yoshino T; Maeda Y
Int J Hematol; 2022 Jul; 116(1):139-145. PubMed ID: 35157240
[TBL] [Abstract][Full Text] [Related]
82. Quantitative analysis of cell-free Epstein-Barr virus genome copy number in patients with EBV-associated hemophagocytic lymphohistiocytosis.
Teramura T; Tabata Y; Yagi T; Morimoto A; Hibi S; Imashuku S
Leuk Lymphoma; 2002 Jan; 43(1):173-9. PubMed ID: 11908724
[TBL] [Abstract][Full Text] [Related]
83. Clinical significance of clonality and Epstein-Barr virus infection in adult patients with hemophagocytic lymphohistiocytosis.
Ahn JS; Rew SY; Shin MG; Kim HR; Yang DH; Cho D; Kim SH; Bae SY; Lee SR; Kim YK; Kim HJ; Lee JJ
Am J Hematol; 2010 Sep; 85(9):719-22. PubMed ID: 20652965
[TBL] [Abstract][Full Text] [Related]
84. Clinical warning of hemophagocytic syndrome caused by Epstein-Barr virus.
Shi J; Chu C; Yu M; Zhang D; Li Y; Fan Y; Yu Y; Luo Y; Zhou W
Ital J Pediatr; 2021 Jan; 47(1):3. PubMed ID: 33413556
[TBL] [Abstract][Full Text] [Related]
85. The spectrum of Epstein-Barr virus-associated lymphoproliferative disease in Korea: incidence of disease entities by age groups.
Cho EY; Kim KH; Kim WS; Yoo KH; Koo HH; Ko YH
J Korean Med Sci; 2008 Apr; 23(2):185-92. PubMed ID: 18436998
[TBL] [Abstract][Full Text] [Related]
86. Prognostic factors in patients with secondary hemophagocytic lymphohistioc ytosis in a Chinese cohort.
Pei Y; Zhu J; Yao R; Cao L; Wang Z; Liang R; Jia Y; Su Y
Ann Hematol; 2024 Mar; 103(3):695-703. PubMed ID: 38265737
[TBL] [Abstract][Full Text] [Related]
87. A Rare Case of Extranodal Natural Killer/T-cell Lymphoma, Nasal Type Associated With Hemophagocytic Lymphohistiocytosis in a Patient With Recurrent Sinusitis.
Christensen BR; Kou CJ; Lee LE
Cureus; 2024 Mar; 16(3):e56237. PubMed ID: 38618451
[TBL] [Abstract][Full Text] [Related]
88. Treatment of Epstein Barr virus-induced haemophagocytic lymphohistiocytosis with rituximab-containing chemo-immunotherapeutic regimens.
Chellapandian D; Das R; Zelley K; Wiener SJ; Zhao H; Teachey DT; Nichols KE;
Br J Haematol; 2013 Aug; 162(3):376-82. PubMed ID: 23692048
[TBL] [Abstract][Full Text] [Related]
89. Serious consequences of Epstein-Barr virus infection: Hemophagocytic lymphohistocytosis.
Xu L; Guo X; Guan H
Int J Lab Hematol; 2022 Feb; 44(1):74-81. PubMed ID: 34709704
[TBL] [Abstract][Full Text] [Related]
90. The Outcome of Induction Therapy for EBV-Related Hemophagocytic Lymphohistiocytosis: A Model for Risk Stratification.
Cui T; Wang J; Wang Z
Front Immunol; 2022; 13():876415. PubMed ID: 35860246
[TBL] [Abstract][Full Text] [Related]
91. [Clinical Characteristics and Prognostic Analysis of 59 Adult Patients with Epstein-Barr Virus-Associated Hemophagocytic Syndrome].
Zhou YL; Li F; Zhang RY; Chen ZW; Zhong N; Tang WP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Apr; 28(2):657-662. PubMed ID: 32319412
[TBL] [Abstract][Full Text] [Related]
92. Epstein-Barr virus-associated T- and NK-cell lymphoproliferative diseases: an update and diagnostic approach.
Hue SS; Oon ML; Wang S; Tan SY; Ng SB
Pathology; 2020 Jan; 52(1):111-127. PubMed ID: 31767131
[TBL] [Abstract][Full Text] [Related]
93. A Pediatric Case Report of Epstein-Barr Virus-associated Hemophagocytic Lymphohistiocytosis With Pericardial Effusion and Multiple Coronary Artery Aneurysms.
Sun G; Yao F; Yang Z
J Pediatr Hematol Oncol; 2021 Mar; 43(2):e219-e222. PubMed ID: 31688637
[TBL] [Abstract][Full Text] [Related]
94. Late-onset posttransplant Epstein-Barr virusrelated lymphoproliferative disease after cord blood transplantation for chronic active Epstein Barr virus infection: A case report.
Yamamoto M; Shindo M; Funayama T; Sumi C; Saito T; Toki Y; Hatayama M; Imadome KI; Mizukami Y; Okumura T
Medicine (Baltimore); 2022 Mar; 101(12):e29055. PubMed ID: 35357349
[TBL] [Abstract][Full Text] [Related]
95. Profiling of EBV-Encoded microRNAs in EBV-Associated Hemophagocytic Lymphohistiocytosis.
Zhou C; Xie Z; Gao L; Liu C; Ai J; Zhang L; Shen K
Tohoku J Exp Med; 2015 Oct; 237(2):117-26. PubMed ID: 26423217
[TBL] [Abstract][Full Text] [Related]
96. An Easily Overlooked Disease: Hemophagocytic Syndrome.
Chen Y; Zhu YM; Gan YL; Jiang J; Jiang T
Clin Lab; 2023 Nov; 69(11):. PubMed ID: 37948476
[TBL] [Abstract][Full Text] [Related]
97. Early Use of Blood Purification in Severe Epstein-Barr Virus-Associated Hemophagocytic Syndrome.
Huang P; Huang C; Xu H; Lu J; Tian R; Wang Z; Chen Y
Pediatrics; 2020 Jun; 145(6):. PubMed ID: 32430444
[TBL] [Abstract][Full Text] [Related]
98. Spontaneous resolution of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.
Belyea B; Hinson A; Moran C; Hwang E; Heath J; Barfield R
Pediatr Blood Cancer; 2010 Oct; 55(4):754-6. PubMed ID: 20806367
[TBL] [Abstract][Full Text] [Related]
99. Cord Blood Transplantation Following Reduced-Intensity Conditioning for Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis during Systemic Lupus Erythematosus Treatment.
Kuriyama T; Kawano N; Yamashita K; Kikuchi I
J Clin Exp Hematop; 2016; 56(2):126-129. PubMed ID: 27980302
[TBL] [Abstract][Full Text] [Related]
100. Requirement for containing etoposide in the initial treatment of lymphoma associated hemophagocytic lymphohistiocytosis.
Song Y; Wang J; Wang Y; Wu L; Wang Z
Cancer Biol Ther; 2021 Dec; 22(10-12):598-606. PubMed ID: 34724875
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
